Your shopping cart is currently empty

YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 μM) with a weak effect on KDM5C (IC50=7.12 μM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $113 | - | In Stock | |
| 5 mg | $278 | - | In Stock | |
| 10 mg | $455 | - | In Stock | |
| 25 mg | $892 | - | In Stock | |
| 50 mg | $1,360 | - | In Stock | |
| 100 mg | $1,980 | - | In Stock | |
| 200 mg | $2,730 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $297 | - | In Stock |
| Description | YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 μM) with a weak effect on KDM5C (IC50=7.12 μM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells. |
| In vitro | YUKA1 selectively inhibits NEK2 autophosphorylation in human cancer cell lines (e.g., MDA-MB-231, BT20, MCF7), leading to mitotic arrest, spindle defects, polyploidy, and increased apoptosis at 10-30 μM (24-48 h). YUKA1 also enhances paclitaxel sensitivity[1]. |
| Synonyms | YUKA 1 |
| Molecular Weight | 292.36 |
| Formula | C13H16N4O2S |
| Cas No. | 708991-09-7 |
| Smiles | S=C1NN=CN1NCC=2C=CC=C(OC)C2OCC=C |
| Relative Density. | no data available |
| Storage | keep away from moisture,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (273.64 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.